Other OTC - Delayed Quote • USD
Interpace Biosciences, Inc. (IDXG)
At close: 3:51 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -0.53 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | -- | -- | 121.68M | -- |
| Low Estimate | -- | -- | 121.68M | -- |
| High Estimate | -- | -- | 121.68M | -- |
| Year Ago Sales | -- | -- | -- | 121.68M |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2022 | 6/30/2022 | 9/30/2022 | |
|---|---|---|---|---|
| EPS Est. | -- | -0.8 | -0.52 | -0.25 |
| EPS Actual | -- | -0.53 | -0.93 | -3.35 |
| Difference | -- | 0.27 | -0.41 | -3.1 |
| Surprise % | -- | 33.80% | -78.80% | -1,240.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 3.19 | 0 |
| 30 Days Ago | 0 | 0 | 3.19 | 0 |
| 60 Days Ago | 0 | 0 | 3.19 | 0 |
| 90 Days Ago | 0 | 0 | 3.19 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | IDXG | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | 15.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -23.06% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 11/17/2021 |
| Maintains | HC Wainwright & Co.: Buy | 4/9/2021 |
| Maintains | HC Wainwright & Co.: Buy | 1/25/2021 |
| Maintains | HC Wainwright & Co.: Buy | 10/22/2020 |
| Maintains | HC Wainwright & Co.: Buy | 6/26/2020 |
| Maintains | HC Wainwright & Co.: Buy | 4/23/2020 |
Related Tickers
PMD Psychemedics Corporation
2.6450
+2.12%
BDSX Biodesix, Inc.
1.2600
-1.56%
FONR FONAR Corporation
16.19
+1.12%
RNVA Rennova Health, Inc.
0.0000
-99.00%
NVTAQ Invitae Corporation
0.0010
-72.22%
FLGT Fulgent Genetics, Inc.
20.74
+0.48%
OPK OPKO Health, Inc.
1.2300
-1.60%
TTOO T2 Biosystems, Inc.
2.7600
+1.47%
ILMN Illumina, Inc.
122.87
-1.28%